SG11202006994XA - Antibacterial compounds, compositions thereof, and methods using same - Google Patents

Antibacterial compounds, compositions thereof, and methods using same

Info

Publication number
SG11202006994XA
SG11202006994XA SG11202006994XA SG11202006994XA SG11202006994XA SG 11202006994X A SG11202006994X A SG 11202006994XA SG 11202006994X A SG11202006994X A SG 11202006994XA SG 11202006994X A SG11202006994X A SG 11202006994XA SG 11202006994X A SG11202006994X A SG 11202006994XA
Authority
SG
Singapore
Prior art keywords
compositions
methods
same
antibacterial compounds
antibacterial
Prior art date
Application number
SG11202006994XA
Inventor
Sean F Brady
James Peek
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of SG11202006994XA publication Critical patent/SG11202006994XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202006994XA 2018-01-24 2019-01-24 Antibacterial compounds, compositions thereof, and methods using same SG11202006994XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862621160P 2018-01-24 2018-01-24
PCT/US2019/014877 WO2019147753A1 (en) 2018-01-24 2019-01-24 Antibacterial compounds, compositions thereof, and methods using same

Publications (1)

Publication Number Publication Date
SG11202006994XA true SG11202006994XA (en) 2020-08-28

Family

ID=67395668

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202006994XA SG11202006994XA (en) 2018-01-24 2019-01-24 Antibacterial compounds, compositions thereof, and methods using same

Country Status (8)

Country Link
US (1) US11325920B2 (en)
EP (1) EP3743060A4 (en)
AR (1) AR114309A1 (en)
AU (1) AU2019212241A1 (en)
CA (1) CA3089236A1 (en)
SG (1) SG11202006994XA (en)
TW (1) TW201944989A (en)
WO (1) WO2019147753A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3089236A1 (en) 2018-01-24 2019-08-01 The Rockefeller University Antibacterial compounds, compositions thereof, and methods using same
GB201812078D0 (en) * 2018-07-24 2018-09-05 Demuris Ltd Novel compounds and their uses
EP4003200A4 (en) 2019-07-23 2023-08-02 The Rockefeller University Antibacterial compounds, compositions thereof, and methods using same
IL294909A (en) 2020-02-13 2022-09-01 Zymergen Inc Metagenomic library and natural product discovery platform
WO2021242849A1 (en) * 2020-05-28 2021-12-02 The Rockefeller University Antibacterial compounds, compositions thereof, and methods using same
CN112051190B (en) * 2020-09-02 2023-08-18 重庆科技学院 Method for evaluating permeability of composite osmotic acid
WO2024076693A1 (en) * 2022-10-05 2024-04-11 Regents Of The University Of Minnesota Rifamycins for nontuberculous mycobacteria

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5169645A (en) 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
CA2132012C (en) 1992-03-25 2003-04-22 John W. Shell Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
KR100325562B1 (en) 1993-05-24 2002-07-22 그루포 레페티트 에스. 피. 에이. 36-derivative of rifamycin and its use as an antimicrobial agent
AU3290397A (en) 1996-06-10 1998-01-07 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
US5972389A (en) 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
US6635280B2 (en) 1997-06-06 2003-10-21 Depomed, Inc. Extending the duration of drug release within the stomach during the fed mode
PT998271E (en) 1997-06-06 2005-10-31 Depomed Inc FORMS OF ORAL DOSAGE OF DRUGS WITH GASTRIC RETENTION FOR THE CONTROLLED LIBERATION OF HIGHLY SOLUABLE DRUGS
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
IL149421A0 (en) 1999-11-02 2002-11-10 Depomed Inc Pharmaceutical compositions containing fed mode inducing agents
AU767812B2 (en) 2000-02-04 2003-11-27 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6451808B1 (en) 2000-10-17 2002-09-17 Depomed, Inc. Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
CA2449009A1 (en) 2001-05-29 2002-12-05 Depomed Development, Ltd Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
US20030091630A1 (en) 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
WO2003035039A1 (en) 2001-10-25 2003-05-01 Depomed, Inc. Methods of treatment using a gastric retained losartan dosage
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US6723340B2 (en) 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US7247634B2 (en) 2004-01-13 2007-07-24 Cumbre Pharmaceuticals Inc. Rifamycin derivatives effective against drug-resistant microbes
US9803002B2 (en) 2013-05-31 2017-10-31 Genentench, Inc. Anti-wall teichoic antibodies and conjugates
CA2965540A1 (en) 2014-12-03 2016-06-09 Genentech, Inc. Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof
CA3089236A1 (en) 2018-01-24 2019-08-01 The Rockefeller University Antibacterial compounds, compositions thereof, and methods using same
GB201812078D0 (en) 2018-07-24 2018-09-05 Demuris Ltd Novel compounds and their uses

Also Published As

Publication number Publication date
US11325920B2 (en) 2022-05-10
WO2019147753A1 (en) 2019-08-01
CA3089236A1 (en) 2019-08-01
AU2019212241A1 (en) 2020-08-13
TW201944989A (en) 2019-12-01
EP3743060A4 (en) 2021-11-03
US20210139509A1 (en) 2021-05-13
AR114309A1 (en) 2020-08-19
EP3743060A1 (en) 2020-12-02

Similar Documents

Publication Publication Date Title
IL272089B1 (en) Compounds, compositions and methods
PT3676297T (en) Compounds, compositions and methods
IL285302A (en) Compounds, compositions and methods
SG11202006994XA (en) Antibacterial compounds, compositions thereof, and methods using same
GB201810492D0 (en) Composition
GB201820878D0 (en) Composition
GB201811100D0 (en) Composition
GB2576614B (en) Compositions, uses and methods
GB201812145D0 (en) Composition
GB201804163D0 (en) Uses, compositions and methods
GB201804434D0 (en) Composition
IL287120A (en) Compounds, compositions and methods
IL261782A (en) Carbapenem compounds, compositions comprising same and uses thereof
IL270505B1 (en) Compounds, compositions and methods
GB201901161D0 (en) Composition
GB201818827D0 (en) Composition
IL276125A (en) Dihydroindolizinone derivative compounds, compositions comprising same and uses thereof
GB201819861D0 (en) Composition
GB201815032D0 (en) Composition
GB201810024D0 (en) Composition
GB201809123D0 (en) Composition
GB201801596D0 (en) Composition
EP4003200A4 (en) Antibacterial compounds, compositions thereof, and methods using same
GB201820082D0 (en) Composition
GB201818567D0 (en) Composition